| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |